| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5566241 | American Journal of Infection Control | 2017 | 7 Pages |
Abstract
Available evidence suggests that antimicrobial PICCs may reduce CLABSI, especially in high-risk subgroups. Randomized trials are needed to assess efficacy across patient populations.
Related Topics
Life Sciences
Immunology and Microbiology
Microbiology
Authors
Rachel D. BS, Mary A.M. PhD, Marisa MLIS, Jason MSA, Sanjay MD, MPH, Vineet MD, MSc,